ACR Image Metrix, a global imaging contract research organisation (CRO) based in the American College of Radiology Clinical Research Center in Philadelphia, US, has welcomed Kathy Freeman as business development manager for the East Coast of the US.
Freeman has extensive experience in sales strategies, team leadership and new market development.
Prior to joining ACR Image Metrix, Freeman held key positions within niche CRO organisations, where she landed numerous contracts in the pharmaceutical and biotech market. She began her career selling specialist pharmaceuticals.
ACR Image Metrix provides imaging CRO services to assist pharmaceutical, biotech and medical device companies around the world.
ACR Image Metrix hires Kathy Freeman
As business development manager for the US East Coast
You may also like
Research & Development
€2.5m boost for SensABLATE to revolutionise real-time lung cancer treatment
The next-generation AI and photonics system is designed to provide instant intraoperative confirmation during lung cancer ablation and aims to improve precision, reduce repeat procedures and enhance patient outcomes
Regulatory
FDA grants Medivir’s MIV-711 Orphan Drug Designation for Osteogenesis Imperfecta treatment
The FDA has awarded Orphan Drug Designation to Medivir’s selective cathepsin K inhibitor MIV-711 for Osteogenesis Imperfecta, a rare genetic bone disorder, after preclinical and clinical data suggests the therapy may strengthen bone
Research & Development
Vivan Therapeutics and MRC LMS launch partnership to study how KRAS mutations, diabetes and diet shape cancer drug response
The new collaboration will investigate how KRAS mutations and metabolic conditions such as diabetes influence chemotherapy effectiveness, using high-throughput in vivo “fly avatar” models
Research & Development
Gates Foundation awards Keltic Pharma $1.3 million for malaria drug research
The University of Glasgow spin-out's malaria programme is moving towards IND enablement within the next 12 months and is designed to deliver a single-dose cure — a potential breakthrough in efforts to combat one of the world’s most lethal diseases